GE HealthCare claims photon-counting CT clearance from FDA
This image was generated by AI and may not depict real events.
GE HealthCare has obtained FDA clearance for its photon-counting CT system, Photonova Spectra, which can capture up to 50 times more data than some premium CT predecessors. The system aims to provide higher resolution and clearer pictures into different kinds of tissue, and can be used across various medical specialties.
GE HealthCare's Photonova Spectra is a new CT system that directly measures the energy of X-ray beams after they pass through the body. This allows for higher resolution and clearer pictures. The system uses Deep Silicon detectors to eliminate electronic noise and lower radiation doses. It can distinguish between materials like calcium, fat, and iodine. The University of Wisconsin-Madison and Stanford Medicine have contributed to its development and testing. Photonova Spectra can be used in neurology, oncology, and other medical specialties. It supports a one-scan approach, reducing protocols and setup time.
This content was automatically generated and/or translated by AI. It may contain inaccuracies. Please refer to the original sources for verification.